Literature DB >> 29767340

Speculation as to why the Frequency of Eosinophilic Esophagitis Is Increasing.

Stuart Jon Spechler1.   

Abstract

PURPOSE OF REVIEW: The frequency of eosinophilic esophagitis (EoE), an immune/antigen-mediated disorder first described in 1993, has been increasing rapidly. The purpose of this review is to consider hypotheses proposed to explain this increase and to speculate on their validity. RECENT
FINDINGS: The hygiene hypothesis attributes the rise of EoE to modern hygienic conditions resulting in fewer childhood infections with microbes that might have protected against allergy development. Microbial dysbiosis, a change in the microbiome's composition and diversity caused by a modern affluent lifestyle, also might contribute to allergic conditions. Environmental factors including modern chemicals contaminating crops, livestock treated with hormones and antibiotics, food additives and processing changes, and pollutants in the air and water conceivably might predispose to EoE. One intriguing hypothesis attributes increasing EoE to increasing use of acid-suppressive medications like proton pump inhibitors, which might prevent peptic digestion of food allergens, increase gastric permeability, and alter the microbiome to favor food allergy development. In a recent pediatric case-control study, use of acid suppressants in infancy was by far the single strongest risk factor identified for later development of EoE. It remains unclear which, if any, of the above factors underlies the rising frequency of EoE. These factors need not be mutually exclusive, and the cause of EoE may well be multifactorial.

Entities:  

Keywords:  Eosinophilic esophagitis; Hygiene hypothesis; Microbial dysbiosis; Proton pump inhibitors; Risk factors

Mesh:

Year:  2018        PMID: 29767340     DOI: 10.1007/s11894-018-0633-x

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  51 in total

1.  Effect of the proton pump inhibitor omeprazole on the gastrointestinal bacterial microbiota of healthy dogs.

Authors:  Jose F Garcia-Mazcorro; Jan S Suchodolski; Katherine R Jones; Stuart C Clark-Price; Scot E Dowd; Yasushi Minamoto; Melissa Markel; Jörg M Steiner; Olivier Dossin
Journal:  FEMS Microbiol Ecol       Date:  2012-03-12       Impact factor: 4.194

Review 2.  White Paper AGA: Drug Development for Eosinophilic Esophagitis.

Authors:  Ikuo Hirano; Stuart Spechler; Glenn Furuta; Evan S Dellon
Journal:  Clin Gastroenterol Hepatol       Date:  2017-03-22       Impact factor: 11.382

3.  Omeprazole increases permeability across isolated rat gastric mucosa pre-treated with an acid secretagogue.

Authors:  Ann M Hopkins; Ciara McDonnell; Niall P Breslin; Colm A O'Morain; Alan W Baird
Journal:  J Pharm Pharmacol       Date:  2002-03       Impact factor: 3.765

Review 4.  Proton pump inhibitor use in infants: FDA reviewer experience.

Authors:  Ii-Lun Chen; Wen-Yi Gao; Aisha P Johnson; Ali Niak; John Troiani; Joyce Korvick; Nancy Snow; Kristina Estes; Amy Taylor; Donna Griebel
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-01       Impact factor: 2.839

Review 5.  The allergy epidemics: 1870-2010.

Authors:  Thomas A E Platts-Mills
Journal:  J Allergy Clin Immunol       Date:  2015-07       Impact factor: 10.793

Review 6.  The immunology of the allergy epidemic and the hygiene hypothesis.

Authors:  Bart N Lambrecht; Hamida Hammad
Journal:  Nat Immunol       Date:  2017-09-19       Impact factor: 25.606

7.  Esomeprazole induces upper gastrointestinal tract transmucosal permeability increase.

Authors:  J M Mullin; M C Valenzano; M Whitby; D Lurie; J D Schmidt; V Jain; O Tully; K Kearney; D Lazowick; G Mercogliano; J J Thornton
Journal:  Aliment Pharmacol Ther       Date:  2008-08-04       Impact factor: 8.171

Review 8.  Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis.

Authors:  Stuart Jon Spechler; Robert M Genta; Rhonda F Souza
Journal:  Am J Gastroenterol       Date:  2007-06       Impact factor: 10.864

9.  Childhood hygienic practice and family education status determine the prevalence of Helicobacter pylori infection in Iran.

Authors:  Mehdi Nouraie; Saeid Latifi-Navid; Houri Rezvan; Amir-Reza Radmard; Mahtab Maghsudlu; Hanieh Zaer-Rezaii; Sadigheh Amini; Farideh Siavoshi; Reza Malekzadeh
Journal:  Helicobacter       Date:  2009-02       Impact factor: 5.753

10.  Proton pump inhibitor use in the U.S. ambulatory setting, 2002-2009.

Authors:  Stephen R Rotman; Tara F Bishop
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

View more
  7 in total

1.  Increasing incidence of eosinophilic esophagitis in Sweden: a nationwide population study.

Authors:  John J Garber; Paul J Lochhead; Amiko M Uchida; Bjorn Roelstraete; David Bergman; Mark S Clements; Jonas F Ludvigsson
Journal:  Esophagus       Date:  2022-06-02       Impact factor: 3.671

Review 2.  Eosinophilic esophagitis: novel concepts regarding pathogenesis and clinical manifestations.

Authors:  Stuart Jon Spechler
Journal:  J Gastroenterol       Date:  2019-07-24       Impact factor: 7.527

3.  Mortality in Eosinophilic Esophagitis - a nationwide, population-based matched cohort study from 2005 to 2017.

Authors:  Lovisa Röjler; John J Garber; Bjorn Roelstraete; Marjorie M Walker; Jonas F Ludvigsson
Journal:  Ups J Med Sci       Date:  2021-08-31       Impact factor: 2.384

Review 4.  Eosinophilic esophagitis-established facts and new horizons.

Authors:  Luc Biedermann; Alex Straumann; Thomas Greuter; Philipp Schreiner
Journal:  Semin Immunopathol       Date:  2021-06-07       Impact factor: 9.623

Review 5.  Early Life Risk Factors in Pediatric EoE: Could We Prevent This Modern Disease?

Authors:  Martina Votto; Gian Luigi Marseglia; Maria De Filippo; Ilaria Brambilla; Silvia Maria Elena Caimmi; Amelia Licari
Journal:  Front Pediatr       Date:  2020-05-29       Impact factor: 3.418

Review 6.  Eosinophilic Esophagitis: Review and Update.

Authors:  Elisa Gomez Torrijos; Rosario Gonzalez-Mendiola; Manuela Alvarado; Robledo Avila; Alicia Prieto-Garcia; Teresa Valbuena; Jesus Borja; Sonsoles Infante; M Pilar Lopez; Eva Marchan; Patricia Prieto; Mar Moro; Ana Rosado; Vanessa Saiz; M Luisa Somoza; Olga Uriel; Angelina Vazquez; Pilar Mur; Paloma Poza-Guedes; Joan Bartra
Journal:  Front Med (Lausanne)       Date:  2018-10-09

7.  Treatment-resistant eosinophilic oesophagitis successfully managed with tofacitinib.

Authors:  Lybil Briscia Mendoza Alvarez; Xiuli Liu; Sarah Glover
Journal:  BMJ Case Rep       Date:  2019-12-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.